HeartFlow
Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.
HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.
At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.
Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com
Can obese patients benefit from the Coronary CTA pathway to diagnose Coronary Artery Disease?
Dr. Maros Ferencik reviews insights from the PRECISE Trial sub study evaluating the difference in test results and outcomes between obese and non-obese patients using a usual testing strategy or coronary computed tomography (CCTA) with selective noninvasive fractional flow reserve (FFRCT).
